University of Oxford

Due to a systemic underfunding of childhood cancer, children in the UK are regularly given treatments developed for adults, often leaving them with life long damage even in the case of survival.

We are beyond honoured to announce that we have donated £101,850 to the University of Oxford’s Department of Paediatrics, to fund the Scientific Advances for Infant Leukaemia (SAIL) programme, a collaboration between the University of Oxford and Great Ormond Street Hospital, to research the development of new, personalised children treatments for acute lymphoblastic leukaemia (ALL), and to create a roadmap for all types of leukaemia.